Gary H Cohen Selected Research

Gary H Cohen Research Topics

Disease

34	Infections 12/2021 - 03/2002
11	Herpes Genitalis (Genital Herpes) 01/2022 - 03/2004
7	Smallpox (Variola) 06/2013 - 03/2004
5	Poxviridae Infections 10/2016 - 11/2005
4	Vaccinia 10/2016 - 01/2007
4	Vesicular Stomatitis 05/2012 - 07/2006
3	Genital Diseases 01/2020 - 03/2011
2	Neoplasms (Cancer) 03/2020 - 01/2017
2	Asymptomatic Infections 01/2019 - 01/2017
1	COVID-19 12/2021
1	Neonatal herpes 11/2020
1	Latent Infection 01/2020
1	Encephalitis (Encephalitis, Rasmussen) 01/2017
1	Virus Diseases (Viral Diseases) 11/2014
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 06/2006
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 11/2005
1	Melanoma (Melanoma, Malignant) 09/2005
1	Zlotogora-Ogur syndrome 05/2004
1	Mpox (monkeypox) 03/2004
1	Herpes Simplex 08/2003

Drug/Important Bio-Agent (IBA)

18	VaccinesIBA 01/2022 - 03/2004
16	Proteins (Proteins, Gene)FDA Link 11/2020 - 08/2003
12	AntibodiesIBA 01/2022 - 03/2003
11	Glycoproteins (Glycoprotein)IBA 11/2020 - 08/2003
9	NectinsIBA 02/2008 - 03/2002
6	Neutralizing AntibodiesIBA 12/2021 - 11/2014
5	EpitopesIBA 01/2022 - 03/2002
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2019
4	NucleosidesIBA 12/2021 - 01/2019
4	Membrane Proteins (Integral Membrane Proteins)IBA 10/2016 - 05/2007
4	Subunit VaccinesIBA 07/2014 - 01/2007
3	mRNA VaccinesIBA 12/2021 - 01/2020
3	AntigensIBA 11/2020 - 01/2017
3	Monoclonal AntibodiesIBA 01/2018 - 12/2003
2	glycoprotein D-herpes simplex virus type 2IBA 01/2022 - 03/2011
2	aluminum sulfate (alum)IBA 11/2020 - 01/2017
2	Recombinant ProteinsIBA 08/2008 - 10/2005
2	Antiviral Agents (Antivirals)IBA 04/2008 - 05/2007
2	Smallpox Vaccine (Vaccine, Smallpox)FDA Link 01/2007 - 03/2004
1	Lipid NanoparticlesIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	CPG-oligonucleotideIBA 01/2017
1	EmulsionsIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 10/2016
1	GTP-Binding Proteins (G-Protein)IBA 05/2012
1	Sulfoglycosphingolipids (Sulfatides)IBA 07/2011
1	LigandsIBA 11/2010
1	GlycosaminoglycansIBA 08/2008
1	Immunoglobulin G (IgG)IBA 08/2008
1	Virulence Factors (Pathogenicity Factors)IBA 04/2008
1	SynaptophysinIBA 07/2006
1	OligodeoxyribonucleotidesIBA 06/2006
1	CXC ChemokinesIBA 06/2006
1	Viral Matrix ProteinsIBA 11/2005
1	Ammonium Chloride (Sal Ammoniac)FDA Link 06/2005
1	bafilomycin A1IBA 06/2005
1	Green Fluorescent ProteinsIBA 04/2005
1	Peptides (Polypeptides)IBA 04/2005
1	Biological Warfare AgentsIBA 03/2004
1	afadinIBA 08/2003

Therapy/Procedure

1	Oncolytic Virotherapy 03/2020
1	Transjugular Intrahepatic Portasystemic Shunt 10/2019
1	Mucosal Administration 06/2006
1	Injections 11/2005
1	Therapeutics 11/2005